Transcept Pharmaceuticals, Inc. uses its proprietary delivery system to enhance the penetration of drugs, significantly speeding their onset of action. Transcept is developing rapid-acting versions of several major market pharmaceuticals. Hamilton co-invested in the company's first institutional round of funding alongside Montreaux Equity Partners, Peninsula Equity Partners and Vivo Ventures. Investors in subsequent financing rounds include these firms, and New Leaf Venture Partners, Interwest Partners and New Enterprise Associates.
Past Team (3)Update
Speciality Finance Company (NYSE: HTGC)
Early Stage Technology Venture Capital
InterWest invests an average of about $7 - 15 million over the span of their involvement with...
Hamilton BioVentures is a venture capital firm (with $100 million under management) investing in...
Health-Care Focused VC Firm
Montreux Equity Partners is a private investment firm dedicated to building the leading...
Global venture capital firm helping entrepreneurs build transformational businesses across...
1003 W. Cutting Blvd
Richmond, CA 94804
- 05/10/06 -nasdaq.com